OH
OHACU
Oceanhawk Acquisition Corp.
$10.14
+1.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 4, 2026
SEC
Oceanhawk Acquisition Corp. filed an 8-K reporting the full exercise of the underwriters' over-allotment option on May 2
8-K — Impact 4/10
Jun 1, 2026
SEC
Two Form 3 filings were submitted by insiders Ernest B. Miller (CEO) and Jon Ryan (CFO & President) of Oceanhawk Acquisi
3 — Impact 2/10
May 29, 2026
SEC
Oceanhawk Acquisition Corp. (OHACU) filed an 8-K reporting the consummation of its initial public offering (IPO) of 18,4
8-K — Impact 3/10
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.0/10.
NEUTRAL
8-K
4/10
Oceanhawk Acquisition Corp. filed an 8-K reporting the full exercise of the underwriters' over-allot
Jun 4, 2026
NEUTRAL
3
2/10
Two Form 3 filings were submitted by insiders Ernest B. Miller (CEO) and Jon Ryan (CFO & President)
Jun 1, 2026
NEUTRAL
8-K
3/10
Oceanhawk Acquisition Corp. (OHACU) filed an 8-K reporting the consummation of its initial public of
May 29, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.